MA Monthly Puff: Massachusetts Cannabis Ballot Measure Poll
October 2026 brings a decisive signal on the Massachusetts cannabis ballot measure, with a new poll showing 71 percent of likely voters plan to reject the November initiative that would roll back adult-use sales. At the same time, the Cannabis Control Commission opened a major regulatory overhaul, and a residency licensing fight reached the U.S. Supreme Court. Boston locked in its remaining hearing dates for the year, so there is plenty moving across the state right now.
Top Headlines This Month
- ⚖️ Poll shows 71 percent oppose cannabis rollback measure
- ⚖️ Commission opens major cannabis regulatory overhaul
- ⚖️ Supreme Court asked to rule on residency licensing
- ⚖️ Boston sets fall and winter license hearings
⚖️ MASSACHUSETTS: POLL SHOWS 71 PERCENT OPPOSE CANNABIS ROLLBACK MEASURE
A University of New Hampshire poll released September 24, 2026 found that 71 percent of likely Massachusetts voters plan to reject the November ballot initiative that would roll back the state’s adult-use cannabis law, while 24 percent said they support it. The measure would repeal the laws allowing regulated commercial sales of recreational cannabis and home cultivation, but it would keep legal possession and the medical marijuana system in place. Opposition held across party lines, with Democrats against it 68 percent to 21 percent, Republicans against it 62 percent to 29 percent, and unaffiliated voters opposed 72 percent to 26 percent. The survey interviewed 564 likely general-election voters between September 17 and 21 and carried a margin of error of plus or minus 4.1 percent. It drew less support than any other Massachusetts ballot initiative included in the poll.
The finding follows an earlier survey that put opposition at 55 percent to 33 percent. Massachusetts has passed $10 billion in adult-use cannabis purchases since sales began in 2018, and Cannabis Control Commission Chair Chris Harding said that, in general, repeal of the adult-use industry could eliminate thousands of jobs, hundreds of businesses and billions in tax revenue. The State Ballot Law Commission rejected a challenge to the measure’s signatures, clearing it to go before voters in November.
⚖️ MASSACHUSETTS: COMMISSION OPENS MAJOR CANNABIS REGULATORY OVERHAUL
The Massachusetts Cannabis Control Commission began a series of public meetings on Sept. 17 to update a wide range of cannabis regulations, its third regulatory round of 2026 following the extension of delivery license exclusivity in March and emergency regulations raising retail ownership caps. The agenda covers medical marijuana licensing, cannabis testing protocols, and registered agent training. Because Chapter 65 of the Acts of 2026 ended the vertical integration requirement for medical marijuana establishments, commissioners will review a new standalone medical dispensary license type along with modifications to authorize transfers from adult-use licensees to medical marijuana establishments. The Commission is also building a new section of 935 CMR dedicated entirely to cannabis testing requirements, pulling its testing standards into one framework. Commissioners plan to vote on three sets of draft regulations at a public meeting in December, with public comment and a public hearing to follow in early 2027 and a final vote in March.
Beyond the Chapter 65 requirements, the fall meetings fold in recommendations from the Red Tape Removal committee, including consideration of statewide license caps, advertising, marketing and loyalty program rules, and authorizing the sale of cannabis seeds at adult- and medical-use retail stores. The December vote and the March finish line give Massachusetts retailers a fixed timeline for when the revised licensing and testing rules will be locked in.
⚖️ FEDERAL: SUPREME COURT ASKED TO RULE ON CANNABIS RESIDENCY LICENSING
Kenneth Gay, a Michigan resident who is the majority owner of California-based Peridot Tree Inc. and Washington-based Peridot Tree WA Inc., filed a petition on Sept. 10 asking the U.S. Supreme Court to decide whether the dormant Commerce Clause’s nondiscrimination principle applies to state and municipal cannabis-licensing schemes. Washington requires prospective cannabis business licensees to have lived in the state for at least six months before applying, and Sacramento allows only current or former residents to apply through its Cannabis Opportunity Reinvestment and Equity (CORE) program. Both rejected Gay’s applications solely because of his residency. Federal district courts dismissed the cases, ruling that the dormant Commerce Clause does not apply to cannabis because of its Schedule I status under the Controlled Substances Act, and in January 2026 the Ninth Circuit affirmed. That created a split with the First Circuit, which found Maine’s residency requirement for medical cannabis business owners unconstitutional in August 2022, and the Second Circuit, which struck down New York‘s adult-use licensing preference for applicants with past cannabis convictions under New York law in August 2025.
Other jurisdictions have enacted protectionist laws that are ripe for challenge, including Alabama, Arkansas, Delaware, the District of Columbia, Nebraska, and New Jersey. A ruling resolving the split would reach well beyond Peridot Tree’s disputes in Washington and Sacramento, affecting licensing structures across the country that favor in-state residents, locally owned businesses, and applicants with specific social histories, such as those disproportionately impacted by prohibition policies.
⚖️ BOSTON: CANNABIS BOARD SETS FALL AND WINTER 2026 LICENSE HEARINGS
The Boston Cannabis Board published its hearing calendar for the rest of 2026. The schedule lists a transactional hearing on October 14, a voting hearing on October 21, a second transactional hearing on December 2, and a second voting hearing on December 9. The city also keeps application materials, retail license saturation analyses, and a directory of host community agreements available through the board’s page. Boston splits its process into two tracks, with transactional hearings and voting hearings handled on separate dates.
This independent board is charged with reviewing all applicants for a cannabis license in the city, so these four dates mark the points where any Boston retail application or license change can advance before the end of the year. Anyone with business before the board now has a fixed window in October and December to plan around.
Source:
https://www.boston.gov/departments/licensing-board/boston-cannabis-board
The Bottom Line
This month the Massachusetts cannabis market saw voters signal strong opposition to the rollback initiative, with a poll putting rejection at 71 percent against 24 percent in support. The Cannabis Control Commission opened a wide regulatory overhaul with a December vote and a March finish, a residency licensing dispute moved to the Supreme Court, and Boston set four license hearings for October and December.
📬 Get Monthly Market Updates
Stay ahead of the curve with our monthly cannabis retail market newsletter. New markets, regulatory changes, and expansion opportunities delivered to your inbox.
